Date: Wednesday 01 Feb 2012
LONDON (ShareCast) - Surgical Innovations Group, a designer and manufacturer of creative solutions for minimally invasive surgery, has received clearance from the US Food and Drug Administration (FDA) for its Logic range of reusable instruments, permitting the use of the range in the US market.
In addition, the company's US master dealer, SI USA, was awarded a contract by the Premier healthcare alliance for the sale of the Group's Resposable Logi range, and Logic range of reusable instruments.
Shares rose half a penny to 11.5p on the morning of the announcements.
NR
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 0.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 2.25 |
52 Week Low | 0.40 |
Volume | 0 |
Shares Issued | 932.82m |
Market Cap | £4.66m |
RiskGrade | 341 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
CEO | David Marsh |
Chair | Jonathan Glenn |
You are here: research